MEI Phar­ma re­ceives un­so­licit­ed of­fer as it pro­ceeds with In­fin­i­ty merg­er

MEI Phar­ma, a San Diego-based biotech, has re­ceived an un­so­licit­ed of­fer to ac­quire its busi­ness.

Last week, as­set man­age­ment com­pa­ny An­son Ad­vi­sors and in­vest­ment firm …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER